HomeCompareNXRA vs SBUX

NXRA vs SBUX: Dividend Comparison 2026

NXRA yields 200000000.00% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NXRA wins by $4.875657285131069e+59M in total portfolio value
10 years
NXRA
NXRA
● Live price
200000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875657285131069e+59M
Annual income
$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full NXRA calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — NXRA vs SBUX

📍 NXRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXRASBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXRA + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NXRA pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXRA
Annual income on $10K today (after 15% tax)
$17,000,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, NXRA beats the other by $414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXRA + SBUX for your $10,000?

NXRA: 50%SBUX: 50%
100% SBUX50/50100% NXRA
Portfolio after 10yr
$2.4378286425655345e+59M
Annual income
$243,782,624,477,893,130,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

NXRA
No analyst data
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXRA buys
0
SBUX buys
0
No recent congressional trades found for NXRA or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXRASBUX
Forward yield200000000.00%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$4.875657285131069e+59M$157.5K
Annual income after 10y$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00$65,840.13
Total dividends collected$4.875656971401711e+59M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: NXRA vs SBUX ($10,000, DRIP)

YearNXRA PortfolioNXRA Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$20,000,010,700$20,000,000,000.00$11,107$407.21+$20000.00MNXRA
2$37,383,218,970,104,910$37,383,197,570,093,464.00$12,512$626.87+$37383218970.09MNXRA
3$65,303,942,472,059,150,000,000$65,303,902,472,014,860,000,000.00$14,366$978.69+$65303942472059152.00MNXRA
4$106,615,009,060,306,890,000,000,000,000$106,614,939,185,088,440,000,000,000,000.00$16,929$1,557.50+$1.0661500906030689e+23MNXRA
5$162,672,273,967,082,950,000,000,000,000,000,000$162,672,159,889,023,270,000,000,000,000,000,000.00$20,658$2,543.80+$1.6267227396708296e+29MNXRA
6$231,966,340,306,755,300,000,000,000,000,000,000,000,000$231,966,166,247,422,140,000,000,000,000,000,000,000,000.00$26,406$4,302.22+$2.319663403067553e+35MNXRA
7$309,138,182,305,146,600,000,000,000,000,000,000,000,000,000,000$309,137,934,101,162,400,000,000,000,000,000,000,000,000,000,000.00$35,877$7,622.00+$3.091381823051466e+41MNXRA
8$385,031,777,252,258,400,000,000,000,000,000,000,000,000,000,000,000,000$385,031,446,474,403,340,000,000,000,000,000,000,000,000,000,000,000,000.00$52,741$14,352.64+$3.850317772522584e+47MNXRA
9$448,184,411,799,345,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000$448,183,999,815,344,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00$85,676$29,243.03+$4.481844117993459e+53MNXRA
10$487,565,728,513,106,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00$157,513$65,840.13+$4.875657285131069e+59MNXRA

NXRA vs SBUX: Complete Analysis 2026

NXRAStock

Nextera Enterprises, Inc., through its subsidiary, W Lab Acquisition Corp., develops and markets consumer products that offer solutions to niche personal care needs. It offers cosmetic remedies for spider veins, dark circles, blotchy skin, bruises, stretch marks, sun spots, at home microdermabrasion kit, and deep facial lines under the Vita-K Solution brand. The company, under the DermaFreeze365 brand, offers instant line relaxing formula as an anti-line and wrinkle cream for the face, neck and chest, and lip areas; and offers two anti-aging compounds: Gamma-Amino Butyric Acid, a new ingredient in modern skin care technology, and BioxiLift, which produces a cumulative reduction in the appearance of fine lines and wrinkles. It also offers Ellin LaVar Textures brand products to address the health and condition of hair and scalp, including OptiMoist Shampoo, SatinSoft Conditioner, LiquidGlass, PenetratingBalm, ReconstructMasque, ThermMist, NourishOil, DetangleMist, LiquidMotion, InstantShine, ScalpRx, and NaturalControl. In addition, the company offers dry shampoo product in an aerosol spray formulation under the Psssssst brand; and a recipe for ageless skin under the Skin Appetit brand. It also markets its products at retail under the Heavy Duty, 40 Carrots, Virtual Laser, Stoppers-4, Bath Lounge, Vita-C2, Firminol-10, and TurboShave brands. The company markets its products to drug, food, and mass-merchandise retail chains through a team of internal sales managers, as well as a sales force of independent sales representatives. Its customers include chain drugstores, mass volume retailers, national mass merchandisers, and grocery chains. Nextera Enterprises, Inc. was founded in 1997 and is based in Panorama City, California.

Full NXRA Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this NXRA vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXRA vs SCHDNXRA vs JEPINXRA vs ONXRA vs KONXRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.